1250 related articles for article (PubMed ID: 25870282)
1. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
[TBL] [Abstract][Full Text] [Related]
2. Neuronal non-CG methylation is an essential target for MeCP2 function.
Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A
Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390
[TBL] [Abstract][Full Text] [Related]
3. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
[TBL] [Abstract][Full Text] [Related]
4. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
Yang W; Pan H
Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
[TBL] [Abstract][Full Text] [Related]
5. Differential brain region-specific expression of MeCP2 and BDNF in Rett Syndrome patients: a distinct grey-white matter variation.
Pejhan S; Siu VM; Ang LC; Del Bigio MR; Rastegar M
Neuropathol Appl Neurobiol; 2020 Dec; 46(7):735-750. PubMed ID: 32246495
[TBL] [Abstract][Full Text] [Related]
6. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation in the gene body influences MeCP2-mediated gene repression.
Kinde B; Wu DY; Greenberg ME; Gabel HW
Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390
[TBL] [Abstract][Full Text] [Related]
8. Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease.
Pejhan S; Rastegar M
Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33429932
[TBL] [Abstract][Full Text] [Related]
9. The molecular basis of variable phenotypic severity among common missense mutations causing Rett syndrome.
Brown K; Selfridge J; Lagger S; Connelly J; De Sousa D; Kerr A; Webb S; Guy J; Merusi C; Koerner MV; Bird A
Hum Mol Genet; 2016 Feb; 25(3):558-70. PubMed ID: 26647311
[TBL] [Abstract][Full Text] [Related]
10. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
[TBL] [Abstract][Full Text] [Related]
11. Losing Dnmt3a dependent methylation in inhibitory neurons impairs neural function by a mechanism impacting Rett syndrome.
Lavery LA; Ure K; Wan YW; Luo C; Trostle AJ; Wang W; Jin H; Lopez J; Lucero J; Durham MA; Castanon R; Nery JR; Liu Z; Goodell M; Ecker JR; Behrens MM; Zoghbi HY
Elife; 2020 Mar; 9():. PubMed ID: 32159514
[TBL] [Abstract][Full Text] [Related]
12. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
[TBL] [Abstract][Full Text] [Related]
13. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
Gadalla KK; Bailey ME; Cobb SR
Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
[TBL] [Abstract][Full Text] [Related]
14. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
Chen RZ; Akbarian S; Tudor M; Jaenisch R
Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
[TBL] [Abstract][Full Text] [Related]
15. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
[TBL] [Abstract][Full Text] [Related]
16. The protocadherins, PCDHB1 and PCDH7, are regulated by MeCP2 in neuronal cells and brain tissues: implication for pathogenesis of Rett syndrome.
Miyake K; Hirasawa T; Soutome M; Itoh M; Goto Y; Endoh K; Takahashi K; Kudo S; Nakagawa T; Yokoi S; Taira T; Inazawa J; Kubota T
BMC Neurosci; 2011 Aug; 12():81. PubMed ID: 21824415
[TBL] [Abstract][Full Text] [Related]
17. The ups and downs of BDNF in Rett syndrome.
Sun YE; Wu H
Neuron; 2006 Feb; 49(3):321-3. PubMed ID: 16446133
[TBL] [Abstract][Full Text] [Related]
18. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor and Rett syndrome.
Katz DM
Handb Exp Pharmacol; 2014; 220():481-95. PubMed ID: 24668484
[TBL] [Abstract][Full Text] [Related]
20. MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain.
Lagger S; Connelly JC; Schweikert G; Webb S; Selfridge J; Ramsahoye BH; Yu M; He C; Sanguinetti G; Sowers LC; Walkinshaw MD; Bird A
PLoS Genet; 2017 May; 13(5):e1006793. PubMed ID: 28498846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
